Published in Arthritis Rheum on November 01, 2005
A decision tree for genetic diagnosis of hereditary periodic fever in unselected patients. Ann Rheum Dis (2006) 1.04
Familial mediterranean Fever: a retrospective clinical and molecular study in the East of anatolia region of Turkey. Open Rheumatol J (2010) 0.87
Familial Mediterranean fever in Germany: epidemiological, clinical, and genetic characteristics of a pediatric population. Eur J Pediatr (2012) 0.86
Familial Mediterranean fever: genotype-phenotype correlations in Japanese patients. Medicine (Baltimore) (2014) 0.84
Intrafamilial segregation analysis of the p.E148Q MEFV allele in familial Mediterranean fever. Ann Rheum Dis (2006) 0.83
Clinical genetic testing of periodic fever syndromes. Biomed Res Int (2013) 0.83
The risk of familial Mediterranean fever in MEFV heterozygotes: a statistical approach. PLoS One (2013) 0.79
Genetic Profile of Patients with Familial Mediterranean Fever (FMF): Single Center Experience at King Hussein Medical Center (KHMC). Med Arch (2015) 0.77
Hereditary autoinflammatory syndromes: a Brazilian multicenter study. J Clin Immunol (2012) 0.77
Familial Mediterranean fever is no longer a rare disease in Japan. Arthritis Res Ther (2016) 0.75
Molecular evaluation of 458 patients referred with a clinical diagnosis of familial Mediterranean fever in Scandinavia. Rheumatol Int (2010) 0.75
Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group. Nat Genet (1999) 3.44
Loss-of-function mutations in a human gene related to Chlamydomonas reinhardtii dynein IC78 result in primary ciliary dyskinesia. Am J Hum Genet (1999) 2.77
Mutations in NALP12 cause hereditary periodic fever syndromes. Proc Natl Acad Sci U S A (2008) 2.06
Expression of the erythropoietin gene. Mol Cell Biol (1986) 2.02
Spectrum of SCN1A gene mutations associated with Dravet syndrome: analysis of 333 patients. J Med Genet (2008) 1.83
Primary myeloproliferative disorder and hepatic vein thrombosis. A prospective study of erythroid colony formation in vitro in 20 patients with Budd-Chiari syndrome. Ann Intern Med (1985) 1.75
Comparison of procalcitonin with C-reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections. Pediatr Infect Dis J (1999) 1.75
Mutations of IDH1 and IDH2 genes in early and accelerated phases of myelodysplastic syndromes and MDS/myeloproliferative neoplasms. Leukemia (2010) 1.75
Genetic linkage of the Muckle-Wells syndrome to chromosome 1q44. Am J Hum Genet (1999) 1.68
Clinical significance of P46L and R92Q substitutions in the tumour necrosis factor superfamily 1A gene. Ann Rheum Dis (2006) 1.67
High insulinlike growth factor I is associated with cognitive decline in Huntington disease. Neurology (2010) 1.61
Search for supersymmetry using final states with one lepton, jets, and missing transverse momentum with the ATLAS detector in √s=7 TeV pp collisions. Phys Rev Lett (2011) 1.60
'Desperate house genes': the dramatic example of hypoxia. Br J Cancer (2010) 1.59
Low levels of ventricular CSF orexin/hypocretin in advanced PD. Neurology (2003) 1.59
A 20-year experience of electron microscopy in the diagnosis of primary ciliary dyskinesia. Eur Respir J (2009) 1.58
RPGR is mutated in patients with a complex X linked phenotype combining primary ciliary dyskinesia and retinitis pigmentosa. J Med Genet (2005) 1.56
PI-103, a dual inhibitor of Class IA phosphatidylinositide 3-kinase and mTOR, has antileukemic activity in AML. Leukemia (2008) 1.55
Non-founder mutations in the MEFV gene establish this gene as the cause of familial Mediterranean fever (FMF). Hum Mol Genet (1998) 1.55
Endothelial dysfunction in patients with sickle cell disease is related to selective impairment of shear stress-mediated vasodilation. Blood (2001) 1.51
Identification of tyrosine residues within the intracellular domain of the erythropoietin receptor crucial for STAT5 activation. EMBO J (1996) 1.49
A 5' splice-region G----C mutation in exon 1 of the human beta-globin gene inhibits pre-mRNA splicing: a mechanism for beta+-thalassemia. Proc Natl Acad Sci U S A (1989) 1.48
Detection of five rare cystic fibrosis mutations peculiar to Southern Italy: implications in screening for the disease and phenotype characterization for patients with homozygote mutations. Clin Chem (1999) 1.44
Mutation in RAP1 is a rare event in myelodysplastic syndromes. Leukemia (2005) 1.44
MEFV-Gene analysis in armenian patients with Familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications. Am J Hum Genet (1999) 1.44
Activity of the caspase-3/CPP32 enzyme is increased in "early stage" myelodysplastic syndromes with excessive apoptosis, but caspase inhibition does not enhance colony formation in vitro. Exp Hematol (2000) 1.43
Air bubbles under vertical vibrations. Eur Phys J E Soft Matter (2006) 1.42
Overlap syndrome between FMF and TRAPS in a patient carrying MEFV and TNFRSF1A mutations. Clin Exp Rheumatol (2007) 1.42
Observation of a centrality-dependent dijet asymmetry in lead-lead collisions at sqrt[S(NN)] =2.76 TeV with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.41
[Periarteritis nodosa in a dental prosthetist]. Presse Med (1994) 1.39
Proteasomes regulate erythropoietin receptor and signal transducer and activator of transcription 5 (STAT5) activation. Possible involvement of the ubiquitinated Cis protein. J Biol Chem (1998) 1.39
Measurement of dijet azimuthal decorrelations in pp collisions at sqrt(s)=7 TeV. Phys Rev Lett (2011) 1.39
Mutations in LHX3 result in a new syndrome revealed by combined pituitary hormone deficiency. Nat Genet (2000) 1.37
The dual mTORC1 and mTORC2 inhibitor AZD8055 has anti-tumor activity in acute myeloid leukemia. Leukemia (2011) 1.37
CFTR gene mutations in adults with disseminated bronchiectasis. Eur J Hum Genet (1997) 1.35
Determination of the strange-quark density of the proton from ATLAS measurements of the W→ℓν and Z→ℓℓ cross sections. Phys Rev Lett (2012) 1.34
Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome. Eur J Hum Genet (2001) 1.34
Search for new particles in two-jet final states in 7 TeV proton-proton collisions with the ATLAS detector at the LHC. Phys Rev Lett (2010) 1.32
A sequence of the CIS gene promoter interacts preferentially with two associated STAT5A dimers: a distinct biochemical difference between STAT5A and STAT5B. Mol Cell Biol (1998) 1.32
Perspectives on inhibiting mTOR as a future treatment strategy for hematological malignancies. Leukemia (2010) 1.32
Production of erythropoietin-like activity by a murine erythroleukemia cell line. Proc Natl Acad Sci U S A (1983) 1.30
Changes in aortic blood flow induced by passive leg raising predict fluid responsiveness in critically ill patients. Crit Care (2006) 1.30
Genetic linkage of recessive dystrophic epidermolysis bullosa to the type VII collagen gene. J Clin Invest (1992) 1.29
Observation of associated near-side and away-side long-range correlations in sqrt[s(NN)]=5.02 TeV proton-lead collisions with the ATLAS detector. Phys Rev Lett (2013) 1.27
Spectrum of CFTR mutations in cystic fibrosis and in congenital absence of the vas deferens in France. Hum Mutat (2000) 1.27
Mutations in the catalytic domain of human coagulation factor IX: rapid characterization by direct genomic sequencing of DNA fragments displaying an altered melting behavior. Genomics (1989) 1.26
Mutations in the autoinflammatory cryopyrin-associated periodic syndrome gene: epidemiological study and lessons from eight years of genetic analysis in France. Ann Rheum Dis (2010) 1.26
Renal granulomatous sarcoidosis: report of six cases. Nephrol Dial Transplant (1990) 1.26
Universality of solar-wind turbulent spectrum from MHD to electron scales. Phys Rev Lett (2009) 1.26
2q23.1 microdeletion identified by array comparative genomic hybridisation: an emerging phenotype with Angelman-like features? J Med Genet (2008) 1.25
Species-specific alternative splice mimicry at the growth hormone receptor locus revealed by the lineage of retroelements during primate evolution. J Biol Chem (2000) 1.23
Tumor cells are the site of erythropoietin synthesis in human renal cancers associated with polycythemia. Blood (1990) 1.20
Search for dark matter candidates and large extra dimensions in events with a photon and missing transverse momentum in pp collision data at sqrt[s]=7 TeV with the ATLAS detector. Phys Rev Lett (2013) 1.19
Syndromic short stature in patients with a germline mutation in the LIM homeobox LHX4. Am J Hum Genet (2001) 1.18
Comparative expression of Hedgehog ligands at different stages of prostate carcinoma progression. J Pathol (2008) 1.17
Clinical versus genetic diagnosis of familial Mediterranean fever. QJM (2000) 1.17
Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever. Am J Hum Genet (2000) 1.16
Purification, amplification and characterization of a population of human erythroid progenitors. Br J Haematol (1999) 1.15
Evaluation of parental mitochondrial inheritance in neonates born after intracytoplasmic sperm injection. Am J Hum Genet (1999) 1.15
Search for a supersymmetric partner to the top quark in final states with jets and missing transverse momentum at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.13
Multimeric structure of the membrane erythropoietin receptor of murine erythroleukemia cells (Friend cells). Cross-linking of erythropoietin with the spleen focus-forming virus envelope protein. J Biol Chem (1991) 1.12
Erythropoietin induces the tyrosine phosphorylation of GAB1 and its association with SHC, SHP2, SHIP, and phosphatidylinositol 3-kinase. Blood (1999) 1.11
Erythropoietin induces the tyrosine phosphorylation of its own receptor in human erythropoietin-responsive cells. J Biol Chem (1992) 1.11
Comment on "Evidence of a cascade and dissipation of solar-wind turbulence at the electron gyroscale". Phys Rev Lett (2013) 1.10
Search for tb resonances in proton-proton collisions at √s=7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.07
Defective membrane expression of human growth hormone (GH) receptor causes Laron-type GH insensitivity syndrome. Proc Natl Acad Sci U S A (1991) 1.06
Light drinking has positive public health consequences. Ann Oncol (2013) 1.05
Hereditary amyloid cardiomyopathy caused by a variant apolipoprotein A1. Am J Pathol (1999) 1.05
Search for a light Higgs boson decaying to long-lived weakly interacting particles in proton-proton collisions at sqrt[s] = 7 TeV with the ATLAS detector. Phys Rev Lett (2012) 1.05
Isolation of several human axonemal dynein heavy chain genes: genomic structure of the catalytic site, phylogenetic analysis and chromosomal assignment. FEBS Lett (1997) 1.03
Different mechanisms inferred from sequences of human mitochondrial DNA deletions in ocular myopathies. Nucleic Acids Res (1991) 1.03
Proteosomes, emulsomes, and cholera toxin B improve nasal immunogenicity of human immunodeficiency virus gp160 in mice: induction of serum, intestinal, vaginal, and lung IgA and IgG. J Infect Dis (1997) 1.03
Pharmacokinetic and imaging studies in patients receiving a formulation of liposome-associated adriamycin. Br J Cancer (1991) 1.02
Prognostic value of prostate circulating cells detection in prostate cancer patients: a prospective study. Br J Cancer (2009) 1.01
A phase Ib GOELAMS study of the mTOR inhibitor RAD001 in association with chemotherapy for AML patients in first relapse. Leukemia (2013) 1.01
Adjuvant effects of liposomes containing lipid A: enhancement of liposomal antigen presentation and recruitment of macrophages. Infect Immun (1992) 1.01
Diagnostic value of serum immunoglobulinaemia D level in patients with a clinical suspicion of hyper IgD syndrome. Rheumatology (Oxford) (2007) 1.01
MR lymphography of abdominal and retroperitoneal lymphatic vessels. AJR Am J Roentgenol (2007) 1.01
Changes in procalcitonin and interleukin 6 levels among treated African patients with different clinical forms of malaria. Trans R Soc Trop Med Hyg (1997) 1.00
Search for supersymmetry in events with three leptons and missing transverse momentum in √[s]=7 TeV pp collisions with the ATLAS detector. Phys Rev Lett (2012) 0.99
c-kit mRNA expression in human and murine hematopoietic cell lines. Oncogene (1989) 0.99
Proteasomes regulate the duration of erythropoietin receptor activation by controlling down-regulation of cell surface receptors. J Biol Chem (2000) 0.99
Systemic administration of doxorubicin-containing liposomes in cancer patients: a phase I study. Eur J Cancer Clin Oncol (1989) 0.98
Erythroid progenitors in polycythemia vera: demonstration of their hypersensitivity to erythropoietin using serum free cultures. Blood (1982) 0.98
Erythropoietin-induced erythroid differentiation of the human erythroleukemia cell line TF-1 correlates with impaired STAT5 activation. EMBO J (1996) 0.98
[Procalcitonin, C-reactive protein and interleukin 6 in bacterial and viral meningitis in children]. Presse Med (1998) 0.97
Liver iron accumulation in patients with chronic active hepatitis C: prevalence and role of hemochromatosis gene mutations and relationship with hepatic histological lesions. J Hepatol (1999) 0.97
A new mutation (A546T) of the betaig-h3 gene responsible for a French lattice corneal dystrophy type IIIA. Am J Ophthalmol (2000) 0.97
AL cardiac amyloidosis and arterial thromboembolic events. Scand J Rheumatol (2005) 0.96
Vivid dreams, hallucinations, psychosis and REM sleep in Guillain-Barré syndrome. Brain (2005) 0.96
Search for the rare leptonic decay B--->tau-nutau. Phys Rev Lett (2005) 0.96
The human dynein intermediate chain 2 gene (DNAI2): cloning, mapping, expression pattern, and evaluation as a candidate for primary ciliary dyskinesia. Hum Genet (2000) 0.95
Screening practices for mutations in the CFTR gene ABCC7. Hum Mutat (2000) 0.95
Identification of a new mutation responsible for hepatoerythropoietic porphyria. Eur J Clin Invest (1991) 0.95